PrEP Generics Entering the US Market: FAQs

Last Updated

The HIV pre-exposure prophylaxis (PrEP) landscape is rapidly changing. With the introduction of new drugs approved for PrEP and generic options becoming available, many changes are underway or on the horizon. This FAQ provides current information on the introduction of PrEP generics, potential coverage changes related to the changing PrEP drug market, and the impact on PrEP access.